Table 1 Demographics and baseline characteristics
Patient background | Placebo | Ramosetron 5 μg | P value |
|---|---|---|---|
(n = 50) | (n = 47) | ||
Age (years) | 40.9 ± 11.11 | 41.0 ± 9.31 | 0.970 |
Duration of disease (months) | 103.9 ± 90.27 | 111.5 ± 129.10 | 0.738 |
Severity of abdominal pain/discomfort (0–4) | 1.43 ± 0.58 | 1.52 ± 0.61 | 0.481 |
Bristol Stool Form Scale (1–7) | 5.55 ± 0.66 | 5.52 ± 0.43 | 0.764 |
Stool frequency (times/day) | 2.77 ± 1.33 | 2.44 ± 1.09 | 0.181 |
IBSSI-J overall score | 246.6 ± 80.52 | 267.1 ± 98.75 | 0.264 |
No symptoms (0–74) | 0 (0.0%) | 1 (2.1%) | - |
Mild (75–174) | 7 (14.0%) | 10 (21.3%) | - |
Moderate (175–299) | 32 (64.0%) | 14 (29.8%) | - |
Severe (300–500) | 11 (22.0%) | 22 (46.8%) | - |